Retraction
Hesperidin methylchalcone (HMC) hinders amyloid-β induced Alzheimer's disease by attenuating cholinesterase activity, macromolecular damages, oxidative stress and apoptosis via regulating NF-κB and Nrf2/HO-1 pathways
Paper Information
Record ID:
46839
Publication Date:
February 15, 2023
Retraction Date:
August 05, 2023
(2.3 years years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Elsevier
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1016/j.ijbiomac.2023.125762Citations (11)
11
Total Citations8
Post-Retraction(72.7%)
3
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
8
Within 1 year
0
After 2+ years
266
Days since retraction (latest)
Neuroprotective Role of Phytoconstituents-based Nanoemulsion for the Treatment of Alzheimer’s Disease
Sukriti Vishwas, Bushra Bashir, Devendra Birla et al. (10 authors)
Current Topics in Medicinal Chemistry
Published: Apr 2024
6 citations
6 citations
266 days after retraction
Natural Medicines (Phytoconstituents) and Probiotics as the Future of Alzheimer’s Disease
Sukriti Vishwas, Monica Gulati, Sachin Kumar Singh et al. (7 authors)
Unknown Journal
Published: Jan 2024
149 days after retraction
Neurotrophic Natural Products
Yoshiyasu Fukuyama, Miwa Kubo, Kenichi Harada
Fortschritte der Chemie Organischer Naturstoffe/Fortschritte der Chemie organischer Naturstoffe/Progress in the chemistry of organic natural products
Published: Jan 2024
7 citations
7 citations
149 days after retraction
Rutin prevents pyroptosis and M1 microglia via Nrf2/Mac-1/caspase-1-mediated inflammasome axis to improve POCD
Yelong Ji, Yuanyuan Ma, Yimei Ma et al. (8 authors)
International Immunopharmacology
Published: Dec 2023
15 citations
15 citations
124 days after retraction
Integrating serum pharmacochemistry and network pharmacology to reveal the active constituents and mechanism of Corydalis Rhizoma in treating Alzheimer’s disease
Yan Lyu, Yu Wang, Jian‐You Guo et al. (10 authors)
Frontiers in Aging Neuroscience
Open Access
Published: Nov 2023
2 citations
2 citations
109 days after retraction
Rosavin thwarts amyloid-β-induced macromolecular damages and neurotoxicity, exhibiting anti-Alzheimer’s disease activity in Wister rat model
Meiyi Huang, Rubo Sui, Lei Zhang et al. (7 authors)
Inflammopharmacology
Published: Sep 2023
4 citations
4 citations
53 days after retraction
Heme oxygenase‐1: The roles of both good and evil in neurodegenerative diseases
Rong Liu, Jiahua Yang, Yinghui Li et al. (5 authors)
Journal of Neurochemistry
Open Access
Published: Sep 2023
32 citations
32 citations
51 days after retraction
2‐Oxoquinoline‐based‐thiosemicarbazones as multitargeting neurotherapeutics against Alzheimer's disease: In vitro and in silico studies of MAO and ChE inhibitors
Rabia Basri, Shamool Fatima, Saquib Jalil et al. (9 authors)
Archiv der Pharmazie
Open Access
Published: Sep 2023
1 citation
1 citation
43 days after retraction
Natural antioxidants that act against Alzheimer’s disease through modulation of the NRF2 pathway: a focus on their molecular mechanisms of action
Grammatiki Alexandra Sidiropoulou, Athanasios Metaxas, Malamati Kourti
Frontiers in Endocrinology
Open Access
Published: Jul 2023
20 citations
20 citations
33 days before retraction
The Overview of Drugs Used in Alzheimer’s Disease and Their Molecular Targets
Sukriti Vishwas, Monica Gulati, Molakpogu Ravindra Babu et al. (15 authors)
Unknown Journal
Published: Jan 2023
2 citations
2 citations
216 days before retraction
Research Progress of Stem Cell Exosomes in Alzheimer’s Disease
良康 古
Bioprocess
Published: Jan 2023
216 days before retraction
Quick Stats
Total Citations:
11
Years Since Retraction:
2.3 years
Open Access:
Yes
Last Checked:
Jul 24, 2025